罂粟碱在导管球囊置入前用于引产:一项随机对照试验
本研究为随机双盲安慰剂对照试验,纳入110名足月初产妇且Bishop评分≤6,在Foley导管球囊置入30分钟内给予80 mg罂粟碱静脉注射或生理盐水。意向性分析显示罂粟碱组Bishop评分差值中位数大于安慰剂组(5 vs 4,P=.025),球囊置入至分娩间隔中位数短于安慰剂组(21小时 vs 26小时,P=.031),24小时内分娩比例更高(65.5% vs 41.8%,P=.012)。
要点
- 罂粟碱组Bishop评分差值中位数5 vs 安慰剂组4(P=.025)。
- 罂粟碱组球囊置入至分娩间隔中位数21小时 vs 安慰剂组26小时(P=.031)。
- 罂粟碱组24小时内分娩比例65.5% vs 安慰剂组41.8%(P=.012)。
核心结论
- Foley导管球囊置入前给予罂粟碱可改善Bishop评分并缩短球囊置入至分娩间隔。
研究设计与样本
- 随机双盲安慰剂对照试验,在单家三级大学附属医院进行。
- 纳入足月引产且初始Bishop评分≤6的孕妇110例。
- 随机接受80 mg罂粟碱静脉注射或0.9%生理盐水,均在Foley导管球囊置入30分钟内给药。
- 共同主要结局为球囊置入前至取出后Bishop评分差值及引产至分娩间隔。
- 同时进行意向性分析和符合方案分析。
主要发现
- 意向性分析中,罂粟碱组Bishop评分差值中位数大于安慰剂组(5[四分位距1-11] vs 4[四分位距0-7],P=.025)。
- 罂粟碱组球囊置入至分娩间隔中位数短于安慰剂组(21小时[四分位距6-95] vs 26小时[四分位距3-108],P=.031)。
- 罂粟碱组24小时内分娩比例高于安慰剂组(65.5% vs 41.8%,P=.012)。
- 两组疼痛评分、满意度评分、分娩结局及新生儿结局相似。
- 符合方案分析结果与意向性分析相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Catheter balloon insertion is a common method for cervical ripening and labor induction. Papaverine and its derivatives are musculotropic antispasmodic drugs that directly induce smooth muscle relaxation. Used during childbirth, these drugs have been suggested to shorten the duration of labor. OBJECTIVE: This study aimed to evaluate the effect of administering papaverine before catheter balloon insertion on changes in Bishop scores and on the labor induction-to-delivery interval. STUDY DESIGN: This randomized, double-blinded, placebo-controlled trial was conducted in a single tertiary university-affiliated hospital. Participants were admitted at term for labor induction with an initial Bishop score of ≤6. Participants were randomized to receive 80 mg intravenous papaverine or 0.9% normal saline solution within 30 minutes of Foley catheter balloon insertion. The co-primary outcomes were the difference in Bishop score from before catheter balloon insertion to after removal and the labor induction-to-delivery interval. The secondary outcomes included maternal pain and satisfaction scores, delivery within 24 hours, and neonatal outcomes. Both intention-to-treat and per-protocol analyses were performed. RESULTS: Overall, 110 women were enrolled. In the intention-to-treat analysis, the median difference in Bishop score was greater in the papaverine group than in the placebo group (5 [interquartile range, 1-11] vs 4 [interquartile range, 0-7], respectively; P=.025), and the median catheter balloon insertion-to-delivery interval was shorter in the papaverine group than in the placebo group (21 hours [interquartile range, 6-95] vs 26 hours [interquartile range, 3-108], respectively; P=.031). A higher proportion of women delivered within 24-hours in the papaverine group than in the placebo group (65.5% vs 41.8%, respectively; P=.012). Pain and satisfaction scores, delivery, and neonatal outcomes were similar between the groups. Similar results were found in the per-protocol analysis. CONCLUSION: Papaverine administration before Foley catheter balloon insertion for cervical ripening resulted in improved Bishop scores and shorter catheter balloon insertion-to-delivery intervals.
引用
- Abu Shqara R, Nakhleh Francis Y, Goldinfeld G, et al. Papaverine prior to catheter balloon insertion for labor induction: a randomized controlled trial. Am J Obstet Gynecol MFM. 2024. PMID: 38825005. doi:10.1016/j.ajogmf.2024.101388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。